Every year, greater than 200,000 American males obtain a prognosis of prostate most cancers – making it probably the most generally identified most cancers amongst males in the USA. Accurate imaging is essential for tumor localization, staging the illness and detecting recurrences. PSMA, an antigen present in excessive ranges on the floor of prostate most cancers cells, is a possible biomarker for the illness. PMSA PET scans use a radioactive tracer to connect to PSMA proteins, that are then mixed with CT or MRI scans to visualise the situation of prostate most cancers cells. In 2020, this know-how acquired FDA approval primarily based on part III scientific trials, which confirmed considerably elevated accuracy for detecting prostate most cancers metastasis in comparison with standard imaging with bone and CT scans. When detected early by PSMA PET scans, recurrent prostate most cancers may be handled by way of a focused method with stereotactic physique radiation remedy, surgical procedure and/or systemic remedy in a customized method.